Article
Meta-analysis of genetic mapping studies in mice reveals candidate epilepsy modifier genes that are outside the current drug development landscape
2025-08-21
Abstract excerpt
<h4>ABSTRACT</h4> <h4>Objective</h4> Despite decades of development in anti-seizure medications, approximately 30% of individuals remain refractory to all treatments, and none of the existing therapies are disease-modifying. Identifying targets outside the current preclinical paradigm is critically important. This study aimed to characterize the landscape of current epilepsy treatments at the level of gene inter...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- a3a405a2-77c3-5d3e-8a47-8d35f9358e8c
- DOI
- 10.1101/2025.08.15.669922
